U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07413224) titled 'Qualitative Effects of AEF0217 in Down Syndrome People' on Feb. 10.
Brief Summary: Following the AEF0217-102 trial (NCT05748405), which investigated the effects of the AEF0217 drug versus placebo, we asked people with Down's syndrome and their caregivers who took part in the trial to share their perceptions of what they experienced or observed in an exploratory manner. This qualitative study collects information through a specific questionnaire developed for this purpose.
Study Start Date: Feb., 2026
Study Type: OBSERVATIONAL
Condition:
Down Syndrome (Trisomy 21)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Aelis Farma
Pub...